Could immunosuppressive drugs reduce recurrence rate after second resection for Crohn disease?

Inflammatory Bowel Diseases

Volumn 10, Issue 5, 2004, Pages 491-495

  Alves, Arnaud ^a   Panis, Yves ^a   Joly, Francisca ^a   Pocard, Marc ^a   Lavergne Slove, Anne ^a   Bouhnik, Yoram ^a   Valleur, Patrice ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Crohn disease; Immunosuppressive drugs; Recurrence; Surgery

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; METHOTREXATE; SALICYLIC ACID DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON ANASTOMOSIS; COLON RESECTION; CONTROLLED STUDY; CROHN DISEASE; FEMALE; FOLLOW UP; HUMAN; ILEUM RESECTION; INTESTINE ANASTOMOSIS; INTESTINE RESECTION; LONG TERM CARE; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RECURRENCE RISK; REOPERATION; STATISTICAL SIGNIFICANCE;

6-MERCAPTOPURINE; ADULT; AZATHIOPRINE; COLON; CROHN DISEASE; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; ILEUM; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; POSTOPERATIVE CARE; RECURRENCE; REOPERATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 4644299098     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200409000-00001     Document Type: Article

References (36)

1. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohns disease. Br J Surg. 2000; 87:1697-1701.
2. Higgens CS, Allan RN. Crohn's disease of the distal ileum. Gut. 1980;21: 933-940.
3. Sachar DB. Patterns of postoperative recurrence in Crohn's disease. Scand J Gastroenterol. 1990;25:35-38.
4. Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of crohn's recurrence after ileal resection. Gastroenterology. 1995;108:1617-1621.
5. Rutgeerts P, Van Assche G, D'Haens G, et al. Ornidazol for prophylaxis of postoperative Crohn's disease: final results of a double blind placebo controlled trial. Gastroenterology. 2002;122:A666 (Abstract).
6. Rutgeerts PJ. Review article: the limitations of corticosteroid therapy in Crohn's disease. Aliment Pharmacol Ther. 2001;15:1515-1525.
7. Hellers G, Cortot A, Jewell D, et al. Oral budenoside for prevention to postsurgical recurrence in Crohn's disease. Gastroenterology. 1999;116: 294-300.
8. Camma C, Giunta M, Rosseli M, et al. Mesalamine in the maintenance treatment of Crohn's disease: a metanalysis adjusted for counfounding variables. Gastroenterology. 1997;113:1465-1473.
9. Lochs H, Mayer M, Fleig WE, et al. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine. European Cooperative Crohn's Disease Study VI. Gastroenterology. 2000;118:264-273.
10. Cottone M, Camma C. Mesalamine and relapse prevention in Crohn's disease. Gastroenterology. 2000;119:597.
11. Bouhnik Y, Lemann M, Mary JY, et al. Long-term follow-up of patients with Crohn's disease treated with azathioprine and 6-mercaptopurine. Lancet. 1996;347:215-219.
12. Pearson DC, May GR, Fick G, et al. Azathioprine for maintaining remission of Crohn's disease. Cochrane Database Syst Rev. 2000; CD000067.
13. Cuillerier E, Lemann M, Bouhnik Y, et al. Azathioprine for prevention of postoperative recurrence in Crohn's disease: a retrospective study. Eur J Gastroenterol Hepatol. 2001;13:1291-1296.
14. McLeod RS, Wolff BG, Steinhart AH, et al. Risk and significance of endoscopic/radiological evidence of recurrent Crohn's disease. Gastroenterology. 1997;113:1823-1827.
15. Korelitz B, Hanauer S, Rutgeerts P, et al. Post-operative prophylaxis with 6MP, 5-ASA, or placebo in Crohn's disease: a 2 year multicenter trial. Gastroenterology. 1998;114:A1011 (Abstract).
16. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg. 2000;231:38-45.
17. Greenstein AJ, Lachman P, Sachar DB, et al. Perforating and nonperforating indications for repeated operations in crohn's disease: evidence of two clinical forms. Gut. 1988;29:588-592.
18. Hofer B, Böttger T, Hernandez-Richter T, et al. The impact of clinical types of disease manifestation on the risk of early postoperative recurrence in Crohn's disease. Hepatogastroenterology. 2001;48:152-155.
19. Yamamoto T, Allan RN, Keighley MRB. Strategy for surgical management of ileocolonic anastomotic recurrence in Crohn's disease. World J Surg. 1999;23:1055-1061.
20. Borley NR, Mortensen NJ, Jewell DP. Preventing postoperative recurrence of Crohn's disease. Br J Surg. 1997;84:1493-1502.
21. Scott NA, Sue-Ling HM, Hughes LE. Anastomotic configuration does not affect recurrence of Crohn's disease after ileocolonic resection. Int J Colorectal Dis. 1995;10:67-69.
22. Hashemi M, Novell R, Lewis AAM. Side-to-side stapled anastomosis may delay recurrence in Crohn's disease. Dis Colon Rectum. 1998;41: 1293-1296.
23. Yamamoto T, Keighley MRB. Smoking and disease recurrence after operation for Crohn's disease. Br J Surg. 2000;87:398-404.
24. Löfberg R, Rutgeerts P, Malchow H, et al. Budenoside prolongs time to relapse in ileal and ileocaccal Crohn's disease. A placebo controlled one year study. Gut. 1996;39:82-86.
25. Nielsen OH, Vainer B, Rask-Madsen J. Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine. Aliment Pharmacol Ther. 2001;15:1699-1708.
26. Connell WR, Kamm MA, Dickson M, et al. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet. 1994;343: 1242-1249.
27. Fraser AG, Jewell DP. Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine: a 30-year study. Gastroenterology. 2000;118:A1471 (Abstract).
28. Lewis JD, Bilker WB, Brensinger C, et al. Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology. 2001;121:1080-1087.
29. Fraser AG, Orchard TR, Jewell DP. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut. 2002;50: 485-489.
30. D'Haens G, Geboes K, Ponette E, et al. Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease. Gastroenterology. 1997;112:1475-1481.
31. Mantzaris GJ, Petraki K, Chiado-Irodanides H, et al. Maintenance therapy with aziathioprine is superior to budenoside in healing endoscopics lesions and improving histology in clinically quiescent Crohn's disease. Gastroenterology. 2002;122:A669 (Abstract).
32. Summer RW, Switz DM, Sessions JT, et al. National cooperative Crohn's disease study: results of drug treatment. Gastroenterology. 1979;77:847-869.
33. Korelitz BI, Adler DJ, Mendelsohn RA, et al. Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease. Am J Gastroenterol. 1993;8:1198-1205.
34. Caprilli R, Andreaoli A, Capurso L, et al. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of postoperative recurrence of Crohn's disease. Aliment Pharmacol Ther. 1994;8:35-43.
35. Brignola C, Cottone M, Pera A, et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Gastroenterology. 1995;108:345-348.
36. McLeod RS, Wolff BG, Steinhart AH, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology. 1995;109:404-413.